JPRN-UMIN000018818招募中未知
Trail against hyperlipidemia Patients with high risks to Investigate the effect ON small dense ldl & idl by using middlE dosE rosuvastatin, atrovastatin, psSk-9 inhibitor(relationship of blood ANGPTL, Sortilin, miRNA and so on level) (PIONEERs in Saitama Study 3) - PIONEERs Study 3
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 300
研究概览
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients considered as inadequated by the investigator and doctor
研究者
相似试验
已完成
不适用
Trail against hyperlipidemia patients with high risks to investigate the effect on small dense LDL-C & IDL by using middle dose Rosuvastatin in SaitamaHyperlipidemiaJPRN-UMIN000006539Ikuo Inoue200
已完成
2 期
Treatment of Hyperlipedemia with Unani formulatioCTRI/2018/05/013864Central Council for Research in Unani Medicine60
招募中
不适用
Hyperlipidemia Therapy TERCET Zabrze RegistryHyperlipidemiasSecondary PreventionNCT03065543Silesian Centre for Heart Diseases25,000
已完成
不适用
Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179)DyslipidemiaNCT01436253Organon and Co2,196
招募中
不适用
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)Diabetic RetinopathyNCT03403686University of Alabama at Birmingham104